What is the Buying Price of Strides Pharma Science Share?

The Buying Price of Strides Pharma Science share is 1075 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Strides Pharma Science Share at Choice?

To buy Strides Pharma Science stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Strides Pharma Science, choose your preferred order type, and place the trade.

What is the PE ratio of Strides Pharma Science Shares?

The Price-to-earnings (P/E) ratio of Strides Pharma Science shares is 18.14. You can compare it with the sector average for relative valuation.

What is the PB ratio of Strides Pharma Science Shares?

The Price to Book (P/B) ratio Strides Pharma Science shares is 3.25. Useful to assess the stock's value relative to its book value.

Is Strides Pharma Science Overvalued?

To assess Strides Pharma Science’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Strides Pharma Science?

The Market Cap of Strides Pharma Science is 9908.57 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Strides Pharma Science Share Price?

The 52 week high and low prices of Strides Pharma Science share price is 1231 & 688.75. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Strides Pharma Science belong to?

Strides Pharma Science belongs to the Healthcare sector.

Strides Pharma Science Share price

STAR

Healthcare Large Cap

1075

19.10 (-1.75%)

NSE

BSE

Last updated on 2 Jun, 2026 | 15:45 IST

BUYSELL

Today's High

1094.10

Today's Low

1060.30

52 Week Low

688.75

52 Week High

1231.00

Free Demat with Zero AMC*

Strides Pharma Science Chart

ChartIQ

TradingView

Strides Pharma Science Share Key Metrics

Volume

2.14 L

Market Cap

9908.57 CR

LTQ@LTP

1@1075.00

ATP

1074.31

Var Margin

20.34 %

Circuit Range

875.3-1312.9

Delivery %

50.71 %

Value

23.02 CR

ASM/GSM

No

Market Lot

1

Summary

2 Jun, 2026 | 15:45 को, Strides Pharma Science का शेयर प्राइस आज ₹1075 पर है, जो दिन के लिए 19.10% की -1.75 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1060.30 और ₹1094.10 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹688.75 से ₹1231.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Strides Pharma Science ने 214239 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹92172714 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹107431 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 1,107500 रही। यह स्टॉक ₹875.3-1312.9 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹23.02 CR है। दिन के लिए डिलीवरी परसेंटेज 50.71% रही। इसके अतिरिक्त, Strides Pharma Science वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Strides Pharma Science Fundamentals

P/E Ratio

18.14

P/B Ratio

3.25

Div. Yield

0.46

Sector P/E

69.94

Sector P/B

2.97

Sec. Div. Yield

0.55

Strides Pharma Science Resistance and Support

Pivot 1105.6

Resistance

First Resistance

1124.8

Second Resistance

1155.5

Third Resistance

1174.7

Support

First Support

1074.9

Second Support

1055.7

Third Support

1025

Strides Pharma Science Shareholding Pattern

2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

27.91%

Mutual Fund

8.56%

Insurance

4.54%

Foreign Institutional Investors

28.68%

Domestic Institutional Investors

1.36%

Retail

28.95%

Others

0%

Total Promoters

MAR '26

27.91%

Strides Pharma Science Corporate Actions

Date	Agenda
2026-05-18	Audited Results & Final Dividend
2026-01-30	Quarterly Results

Strides Pharma Science News

Strides Pharma Science Limited

Strides Pharma Science Limited announced the scheme of demerger involving Arco Lab Private Limited and Pivot Path Private Limited became effective on June 1, 2026. This follows the NCLT Order approval received on May 25, 2026, formalizing the separation of the identified business.

Jun 01 2026 17:25:02

Strides Pharma Science Limited

Strides Pharma Science will participate in an in-person US Pharma & Healthcare Tour group meeting for analysts and institutional investors on June 1, 2026, in New York, USA. The meeting will discuss the Q4 FY26 Earnings Presentation.

May 28 2026 20:16:14

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Strides Pharma Science will conduct non-deal investor roadshows in New York, Chicago, Salt Lake City, and Los Angeles from June 2-5, 2026. These one-on-one meetings will utilize the Q4 FY26 earnings presentation as the discussion document for institutional investors.

May 28 2026 20:11:00

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Strides Pharma Science is scheduled to participate in a Non-Deal Road Show in the USA from June 2 to June 5, 2026. The company will conduct in-person one-on-one meetings with analysts and institutional investors across four cities: New York, Chicago, Salt Lake City, and Los Angeles. The discussions will include the Q4 FY26 earnings presentation.

May 28 2026 20:07:31

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Strides Pharma Science is scheduled to participate in a Non-Deal Road Show in the USA from June 2 to June 5, 2026. The company will conduct in-person one-on-one meetings with analysts and institutional investors across four cities: New York, Chicago, Salt Lake City, and Los Angeles. The discussions will include the Q4 FY26 earnings presentation.

May 28 2026 20:05:01

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Strides Pharma Science is scheduled to participate in a Non-Deal Road Show in the USA from June 2 to June 5, 2026. The company will conduct in-person one-on-one meetings with analysts and institutional investors across four cities: New York, Chicago, Salt Lake City, and Los Angeles. The discussions will include the Q4 FY26 earnings presentation.

May 28 2026 20:01:45

Strides Pharma Science Limited

Strides Pharma received a USFDA Form 483 with five observations after a cGMP inspection at its Bangalore facility. The company will respond to the observations within the stipulated time, with potential implications for compliance and operations.

May 20 2026 22:10:13

Strides Pharma Science Ltd - 532531 - Completion Of US-FDA Inspection At The Company'S Flagship Facility In Bangalore

Strides Pharma Science's flagship manufacturing facility in Bangalore underwent a US-FDA inspection, resulting in a Form 483 with five observations. The company will address these observations promptly to the FDA.

May 20 2026 22:02:30

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Change in Directorate

Strides Pharma Science has elevated Mr. Venkata Seetharama Raju Pakalapati from COO to Executive Director for a 3-year term, effective June 1, 2026. Concurrently, Mr. Aditya Arun Kumar has been redesignated from Executive Director to Non-Executive Director.

May 20 2026 15:58:16

Strides Pharma Science Limited

Strides Pharma appointed Venkata Seetharama Raju Pakalapati as Executive Director and Key Managerial Personnel (KMP), effective June 1, 2026. He will oversee global technical operations and strategic management.

May 20 2026 15:50:08

Name	Position
Arun Kumar	Chairman
Kausalya Santhanam	Non Executive Independent Director

Strides Pharma Science Similar Stocks

Sanofi Consumer Healthcare India Ltd.

4670.90

84.20 (1.84%)

Viyash Scientific Ltd.

249.95

-0.45 (0.18%)

Marksans Pharma Ltd.

241.19

2.51 (1.05%)

Concord Biotech Ltd.

1166.20

104.90 (9.88%)

CORONA Remedies Ltd.

1700.50

22.20 (1.32%)

Shilpa Medicare Ltd.

517.35

18.10 (3.63%)

Healthcare Global Enterprises Ltd.

631.65

-14.50 (2.24%)

Jupiter Life Line Hospitals Ltd.

1314.60

9.30 (0.71%)

Procter & Gamble Health Ltd.

6030.50

-32.50 (0.54%)

Sudeep Pharma Ltd.

776.90

-3.60 (0.46%)

Strides Pharma Science FAQs

Strides Pharma Science शेयर का खरीद मूल्य 1075 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Strides Pharma Science शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Strides Pharma Science शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 18.14 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Strides Pharma Science शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.25 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Strides Pharma Science शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.97 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Strides Pharma Science का मार्केट कैप 9908.57 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Strides Pharma Science शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1231.00 और 688.75 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।